Multiplex Sepsis Biomarker Panels Market

Future Market Insights

Multiplex Sepsis Biomarker Panels Market

Key Insight

The multiplex sepsis biomarker panels market is projected to grow from USD 162.6 million in 2025 to USD 325.9 million by 2035, at a CAGR of 7.2%. PCR-based multiplex assays will dominate with a 28.9% market share, while pathogen-specific biomarkers will lead the biomarker type segment with a 56.8% share.

October 30, 2025

Anurag Sharma

250 Pages

Cite this Report

Multiplex Sepsis Biomarker Panels Market

https://www.futuremarketinsights.com/reports/multiplex-sepsis-biomarker-panels-market

License

Buy Now

Summary ToC Companies

Key Players

Assay Genie Ltd
EDX Medical Group plc
GCC Biotech INDIA Pvt Ltd
Seegene Inc

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Multiplex Sepsis Biomarker Panels Market

Key Players

Similar Industry Reports